Building the process-drug–side effect network to discover the relationship between biological Processes and side effects

BackgroundSide effects are unwanted responses to drug treatment and are important resources for human phenotype information. The recent development of a database on side effects, the side effect resource (SIDER), is a first step in documenting the relationship between drugs and their side effects. It is, however, insufficient to simply find the association of drugs with biological processes; that relationship is crucial because drugs that influence biological processes can have an impact on phenotype. Therefore, knowing which processes respond to drugs that influence the phenotype will enable more effective and systematic study of the effect of drugs on phenotype. To the best of our knowledge, the relationship between biological processes and side effects of drugs has not yet been systematically researched.MethodsWe propose 3 steps for systematically searching relationships between drugs and biological processes: enrichment scores (ES) calculations, t-score calculation, and threshold-based filtering. Subsequently, the side effect-related biological processes are found by merging the drug-biological process network and the drug-side effect network. Evaluation is conducted in 2 ways: first, by discerning the number of biological processes discovered by our method that co-occur with Gene Ontology (GO) terms in relation to effects extracted from PubMed records using a text-mining technique and second, determining whether there is improvement in performance by limiting response processes by drugs sharing the same side effect to frequent ones alone.ResultsThe multi-level network (the process-drug-side effect network) was built by merging the drug-biological process network and the drug-side effect network. We generated a network of 74 drugs-168 side effects-2209 biological process relation resources. The preliminary results showed that the process-drug-side effect network was able to find meaningful relationships between biological processes and side effects in an efficient manner.ConclusionsWe propose a novel process-drug-side effect network for discovering the relationship between biological processes and side effects. By exploring the relationship between drugs and phenotypes through a multi-level network, the mechanisms underlying the effect of specific drugs on the human body may be understood.

[1]  Eric Brill,et al.  A Simple Rule-Based Part of Speech Tagger , 1992, HLT.

[2]  V. Goldberg,et al.  Estradiol and tamoxifen stimulation of lapine articular chondrocyte prostaglandin synthesis. , 1983, Prostaglandins.

[3]  Michael J. Keiser,et al.  Predicting new molecular targets for known drugs , 2009, Nature.

[4]  R. Kesterson,et al.  Utilization of conditional alleles to study the role of the primary cilium in obesity. , 2009, Methods in cell biology.

[5]  Alberto Dávalos,et al.  Synergistic upregulation of low-density lipoprotein receptor activity by tamoxifen and lovastatin. , 2004, Cardiovascular research.

[6]  M. Diederich,et al.  Pro-Inflammatory Cytokine-Mediated Anemia: Regarding Molecular Mechanisms of Erythropoiesis , 2010, Mediators of inflammation.

[7]  M. Ashburner,et al.  Gene Ontology: tool for the unification of biology , 2000, Nature Genetics.

[8]  Jing Li,et al.  Polyphenol contents in grape-seed extracts correlate with antipica effects in cisplatin-treated rats. , 2005, Journal of alternative and complementary medicine.

[9]  P. Bork,et al.  A side effect resource to capture phenotypic effects of drugs , 2010, Molecular systems biology.

[10]  M. Neeman,et al.  Metabolic studies of estrogen- and tamoxifen-treated human breast cancer cells by nuclear magnetic resonance spectroscopy. , 1989, Cancer research.

[11]  Pablo Tamayo,et al.  Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[12]  A P Andreeva,et al.  [Antioxidant activity of blood serum amd erythrocytes in patients with refractory anemia]. , 1991, Gematologiia i transfuziologiia.

[13]  David S. Wishart,et al.  DrugBank: a knowledgebase for drugs, drug actions and drug targets , 2007, Nucleic Acids Res..

[14]  Min Song,et al.  Detecting duplicate biological entities using Shortest Path Edit Distance , 2010, Int. J. Data Min. Bioinform..

[15]  P. Bork,et al.  Drug Target Identification Using Side-Effect Similarity , 2008, Science.

[16]  Baolin Wu,et al.  Cancer outlier differential gene expression detection. , 2007, Biostatistics.

[17]  J.,et al.  The New England Journal of Medicine , 2012 .

[18]  Lee Bennett,et al.  Tamoxifen functions as a molecular agonist inducing cell cycle-associated genes in breast cancer cells. , 2003, Molecular cancer research : MCR.

[19]  Andrew McCallum,et al.  Conditional Random Fields: Probabilistic Models for Segmenting and Labeling Sequence Data , 2001, ICML.

[20]  Young-Gyu Ko,et al.  Cathepsin D and eukaryotic translation elongation factor 1 as promising markers of cellular senescence. , 2009, Cancer research.

[21]  Shunji Suzuki,et al.  Serum adenosine deaminase activity in women with hyperemesis gravidarum. , 2002, Clinica chimica acta; international journal of clinical chemistry.

[22]  D. Carney,et al.  Chemotherapy induced nausea and vomiting. , 1994, Irish medical journal.

[23]  Paul A Clemons,et al.  The Connectivity Map: Using Gene-Expression Signatures to Connect Small Molecules, Genes, and Disease , 2006, Science.

[24]  C EZRIN,et al.  The clinical and metabolic effects of glucagon. , 1958, Canadian Medical Association journal.

[25]  Daniel Metzger,et al.  Premature Aging in Skeletal Muscle Lacking Serum Response Factor , 2008, PloS one.

[26]  D. Remick,et al.  Cytokines and the brain: implications for clinical psychiatry. , 2000, The American journal of psychiatry.